In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. (Record no. 19306434)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02208 a2200649 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515194432.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201002s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1532-1827 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/sj.bjc.6605448 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | El-Sahwi, K |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20100209 |
245 00 - TITLE STATEMENT | |
Title | In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | British journal of cancer |
Date of publication, distribution, etc. | Jan 2010 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 134-43 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adenocarcinoma, Papillary |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibody-Dependent Cell Cytotoxicity |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Complement System Proteins |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytotoxicity, Immunologic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dimerization |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Screening Assays, Antitumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Synergism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunoglobulin G |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | In Vitro Techniques |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interleukin-2 |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Killer Cells, Natural |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphocytes |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, ErbB-2 |
General subdivision | biosynthesis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Signal Transduction |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Trastuzumab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Uterine Neoplasms |
General subdivision | pathology |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bellone, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cocco, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cargnelutti, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Casagrande, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bellone, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Abu-Khalaf, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Buza, N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tavassoli, F A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hui, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Silasi, D-A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Azodi, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schwartz, P E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rutherford, T J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pecorelli, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Santin, A D |
773 0# - HOST ITEM ENTRY | |
Title | British journal of cancer |
Related parts | vol. 102 |
-- | no. 1 |
-- | p. 134-43 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/sj.bjc.6605448">https://doi.org/10.1038/sj.bjc.6605448</a> |
Public note | Available from publisher's website |
No items available.